CN115160415B - BmoR protein mutant specifically responding to n-butanol and application thereof - Google Patents

BmoR protein mutant specifically responding to n-butanol and application thereof Download PDF

Info

Publication number
CN115160415B
CN115160415B CN202110361566.7A CN202110361566A CN115160415B CN 115160415 B CN115160415 B CN 115160415B CN 202110361566 A CN202110361566 A CN 202110361566A CN 115160415 B CN115160415 B CN 115160415B
Authority
CN
China
Prior art keywords
ala
leu
arg
gly
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110361566.7A
Other languages
Chinese (zh)
Other versions
CN115160415A (en
Inventor
霍毅欣
陈振娅
毋彤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Institute of Technology BIT
Original Assignee
Beijing Institute of Technology BIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Institute of Technology BIT filed Critical Beijing Institute of Technology BIT
Priority to CN202110361566.7A priority Critical patent/CN115160415B/en
Publication of CN115160415A publication Critical patent/CN115160415A/en
Application granted granted Critical
Publication of CN115160415B publication Critical patent/CN115160415B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Abstract

The invention belongs to the technical field of bioengineering, and particularly relates to a BmoR protein mutant specifically responding to n-butanol and application thereof in n-butanol detection or a biosensor. The BmoR protein mutant is obtained by mutating I183T and/or D273N on the basis of a wild BmoR protein shown in a sequence table SEQ ID NO. 1. The I183T, D N and I183T/D273N mutants are only sensitive to N-butanol and do not respond to isobutanol, so that the problem that the wild BmoR protein cannot distinguish N-butanol from isobutanol high-yield strains is solved; meanwhile, the detection range of I183T/D273N to N-butanol reaches 0-100mM, so that the response saturation of BmoR protein to N-butanol is improved, and the BmoR protein can be used for screening and application of strains with higher yields.

Description

BmoR protein mutant specifically responding to n-butanol and application thereof
Technical field:
the invention belongs to the technical field of bioengineering, and particularly relates to a BmoR protein mutant specifically responding to n-butanol and application thereof in n-butanol detection or a biosensor.
The background technology is as follows:
the synthesis of n-butanol by microorganisms is an important transportation fuel, and the synthesis of n-butanol by metabolic engineering is realized in many microbial hosts, and the transformation of host strains and the screening of high-yield hosts are the basis and key for realizing the industrial production of alcohols. Biosensors are capable of specifically responding to a target compound to output a protein signal that is convenient for detection, and thus have been widely used for high-throughput screening.
The biosensor consists of a molecular recognition element and a signal transducer. When the molecular recognition element is combined with the detected object, the generated signal can be converted into an optical signal or an electric signal through a converter, and the detected object can be detected and analyzed. As a synthetic biology emerging tool, biosensors can be designed to be constructed to dynamically respond to changes in signal molecule concentration. Meanwhile, the biosensor is designed to promote optimization of a microbial cell factory and production of a series of natural products widely used in industry, such as itaconic acid, fatty acid, isobutanol, n-butanol and alkaloids. The biosensor mainly comprises an RNA nucleic acid switch, a transcription factor-regulated biosensor, a G protein coupled receptor and a fluorescent protein biosensor. The low dynamic range of fluorescent protein biosensors, the difficulty in-vitro RNA nucleic acid switching, the fact that G protein-coupled receptors can only be performed outside cells, and the like have prevented the development of biosensors in the biological world.
Transcription Factor (TF) -based biosensors are most widely used. The most commonly used transcription factors are bacterial transcription factors, including Ligand Binding Domains (LBD) or Metabolic Binding Domains (MBD) and DNA Binding Domains (DBD). Bmor is a transcription factor of the Pseudomonas n-paraffin metabolic pathway, a member of bEBP, for modulating sigma of alkane monooxygenases 54 Dependent promoter P bmo The signal molecule is a C2-C5 linear or branched alcohol. However, the wild transcription factor Bmor has poor response specificity, can respond to both n-butanol and isobutanol, and cannot specifically respond to one of the alcohols, thereby meeting the industrial requirements; and narrow detection range (0-40 mM), and cannot be widely applied to biosensors. Therefore, achieving a specific response to alcohol and increasing the detection range are urgent problems to be solved.
The BmoR protein mutant obtained by protein modification not only can realize specific response to n-butanol, but also can improve the upper limit of substrate detection and response intensity of the BmoR protein mutant, and provides a solution for high-efficiency detection of n-butanol and rapid screening of high-yield strains.
The invention comprises the following steps:
the invention aims to provide BmoR protein capable of distinguishing n-butanol and isobutanol, a biosensor and application thereof. A random mutation library is constructed by utilizing an error-prone PCR technology, and the mutant library is screened and analyzed by exogenously adding n-butanol and isobutanol, so that BmoR mutant proteins responding to only n-butanol are finally obtained.
Further, the Bmo R mutant protein which only responds to N-butanol is obtained by generating I183T and/or D273N mutation based on the wild Bmo R protein shown in a sequence table SEQ ID NO.1, hereinafter referred to as I183T mutant, D273N mutant and I183T/D273N mutant (simultaneously generating I183T and D273N mutation), and the mutant proteins are specifically:
(1) Amino acid sequences shown in SEQ ID NO.3, 5 or 7 of the sequence list; or (b)
(2) Amino acid sequence with homology of more than 75% of SEQ ID NO.3, 5 or 7; or (b)
(3) One or more amino acid substitutions, and/or deletions, and/or additions are made on the basis of SEQ ID NO.3, 5 or 7 to obtain an amino acid sequence with the same function as SEQ ID NO.3, 5 or 7.
Further, the invention also provides coding genes of the I183T mutant, the D273N mutant and the I183T/D273N mutant;
further, the coding gene is shown in sequence table SEQ ID NO.4, 6 or 8.
It is a further object of the present invention to provide the use of the I183T mutant, the D273N mutant or the I183T/D273N mutant, in particular in the detection of N-butanol containing samples or the screening of N-butanol producing strains, more particularly in the construction of biosensors for the detection of N-butanol;
further, the biosensor is based on an I183T mutant, a D273N mutant or an I183T/D273N mutant, and the biosensor is a biosensor comprising an I183T mutant, a D273N mutant or an I183T/D273N mutant encoding gene and a promoter, a promoter P thereof bmo An expression element for a reporter gene; the promoter initiates expression of the bmoR gene, and the bmoR protein binds to the alcohol molecule to form hexamers, thereby initiating the downstream promoter P bmo Thereby expressing the reporter gene and generating signals such as fluorescence; the biosensor can realize specific response and screening of n-butanol at the concentration of 0-100mM, and is further applied to industrial production to realize specific screening of n-butanol-containing samples and n-butanol production strains;
further, promoters of the mutant encoding genes include, but are not limited to, P bmoR 、P tac 、P T7 、 P LlacO1 Etc.;
further, the reporter genes include, but are not limited to, gfp, rfp, cfp, sfgfp, egfp, yfp, ecfp isogenes;
preferably, the biosensor comprises an I183T mutant, a D273N mutant or an I183T/D273N mutant encoding gene and a promoter P thereof bmoR Promoter P bmo Recombinant plasmids of gfp reporter genes; further, expression vectors optionally used for the recombinant plasmid include, but are not limited to, expression vectors commonly used in the art, such as pET, pUC19, pMAL, etc.;
more preferably, the biosensor is obtained by replacing the wild BmoR protein encoding gene on plasmid pYH1 with the I183T mutant, D273N mutant or I183T/D273N mutant encoding gene, i.e. will be composed of P bmoR The started I183T mutant, D273N mutant or I183T/D273N mutant coding gene is connected to colE1 replication initiation site and amp r And P bmo A driven gfp gene;
further, the n-butanol producing strain includes, but is not limited to, escherichia coli, saccharomyces cerevisiae, bacillus subtilis, and the like;
further, the promoter P bmoR The nucleotide sequence of (2) is shown as SEQ ID NO.9 of the sequence table;
further, the promoter P bmo The nucleotide sequence of (2) is shown as SEQ ID NO.10 of the sequence table;
further, the nucleotide sequence of the gfp reporter gene is shown in a sequence table SEQ ID NO. 11.
The invention also provides application of the biosensor in n-butanol detection, especially in n-butanol-containing environment, food, medical and biological samples or n-butanol production strain screening, and the biosensor is used for detecting n-butanol production by introducing the plasmid into a production strain, such as escherichia coli, saccharomyces cerevisiae, bacillus subtilis and the like, or introducing the plasmid into a separate host (such as escherichia coli XL10-Gold and the like) and then adding the plasmid into a detection system.
The beneficial effects are that:
1. the BmoR-based biosensor can be used for screening high-yield N-butanol or isobutanol strains, but wild BmoR has response to N-butanol and isobutanol, can not be distinguished, has poor specificity, and the I183T, D273N and I183T/D273N mutants provided by the invention are only sensitive to N-butanol and have no response to isobutanol, so that the problem that the wild BmoR protein can not distinguish N-butanol and isobutanol is solved.
2. The detection range of the wild BmoR is too narrow, the detection range of the normal butanol is 0-40mM, and the response is saturated when the substrate concentration reaches 40mM, so that the BmoR can not be used for identifying the strain with the normal butanol yield higher than 40 mM. The detection range of the I183T/D273N mutant provided by the invention for N-butanol reaches 0-100mM, so that the response saturation of BmoR protein for N-butanol is improved, and the BmoR mutant can be used for screening and applying strains produced in high-level N-butanol.
Description of the drawings:
FIG. 1 is a schematic flow chart;
firstly, randomly mutating 1000bp before the N end of a wild Bmo R by error-prone PCR to obtain a Bmo R random mutation library; GFP fluorescent protein is added downstream of the bmOR gene, and the response of the mutant Bmor to n-butanol can be reflected by detecting the fluorescence intensity. The response of the mutant BmoR to alcohol molecules was tested by adding different concentrations of n-butanol.
FIG. 2 is a graph showing the response of BmoR mutants and wild type to 10mM n-butanol and isobutanol;
FIG. 3 is a graph showing the response of BmoR mutants and wild type to 0-100mM n-butanol and isobutanol;
FIG. 4 shows the molecular docking of the I183T/D273N mutant with N-butanol and isobutanol.
The specific embodiment is as follows:
the invention is described below by means of specific embodiments. The technical means used in the present invention are methods well known to those skilled in the art unless specifically stated. Further, the embodiments should be construed as illustrative, and not limiting the scope of the invention, which is defined solely by the claims. Various changes or modifications to the materials ingredients and amounts used in these embodiments will be apparent to those skilled in the art without departing from the spirit and scope of the invention.
The biosensor provided by the invention is based on an I183T mutant, a D273N mutant or an I183T/D273N mutant, and comprises an I183T mutant, a D273N mutant or an I183T/D273N mutant coding gene, a promoter thereof and a promoter P bmo An expression element for a reporter gene; the promoter initiates expression of the bmoR gene, and the bmoR protein binds to the alcohol molecule to form hexamers, thereby initiating the downstream promoter P bmo Thereby expressing the reporter gene and generating a signal such as fluorescence. The person skilled in the art can choose a promoter to promote the expression of BmR mutant gene in the prior art according to the actual situation, e.g.by using P bmoR 、P tac 、P T7 、P LlacO1 Such promoters. The reporter gene may be selected from various protein molecules commonly used in the art, such as fluorescent proteins, colored proteins, etc., capable of producing a visual detection signal, or small molecule substances available for detection, to effect the response of the biosensor of the present invention, preferably gfp, rfp, cfp, sfgfp, egfp, yfp, ecfp, etc. The sensor also comprises necessary elements for realizing expression, such as a replication initiation site, and preferably, a colE1 replication initiation site, and the like. The sensor may further comprise a marker such as a resistance gene, e.g. amp r And the like, and is convenient for screening. The person skilled in the art can add other elements to the above-mentioned sensor according to actual requirements, such as constructing the above-mentioned elements onto expression vectors in the prior art, such as pET, pUC19, pMAL, etc., to obtain recombinant plasmids that can be used as sensors.
Materials, reagents and the like used in the examples described below are commercially available unless otherwise specified.
The invention will be further illustrated by the following examples.
Example 1 screening of Bmor mutants I183T, D273N and I183T/D273N
Construction of random mutation library of transcription factor Bmor
(1) With a gene encoding the wild Bmor (SEQ ID NO.2) plasmid pYH1 (see DOI for construction: https:// doi.org/10.1016/j.ymben.2019.08.015; https:// doi.org/10.1186/s 12934-019-1084-2) as template, and the bmOR mutant gene was amplified by error-prone PCR (by adding Mn to the PCR system) 2+ Improving Mg in PCR system 2+ The concentration and ratio of dNTPs were adjusted to introduce random mutations. A10 Ximbalanced dNTPs mixture was prepared, in which the concentration of dCTP, dTTP was four times that of dATP, dGTP. The PCR procedure was set as follows: the pre-denaturation at 94℃for 2min,30 amplification cycles included: denaturation at 95℃for 1min, annealing at 55-68℃for 1min, and proper extension time at 72℃was determined according to an amplification rate of 1kb per minute. The storage temperature was set at 16 ℃. ) The method comprises the steps of carrying out a first treatment on the surface of the Confirming the PCR product by gel electrophoresis, and recovering and purifying; the purified product was placed in a 37℃water bath and DpnI (1. Mu.L/50. Mu.L of purified product) was digested for 1-2h. mu.L of the bmoR mutant fragment (while taking the bmoR wild-type fragment as a control) and 3. Mu.L of the pYH1 backbone (P-constructed can also be used bmoR (or other promoters), P bmo The plasmids of gfp fluorescent protein genes (or other reporter genes) are taken as a skeleton and are equivalent to the effect of the pYH1 skeleton) and 5 mu L Gibson Assemble Mix, and the plasmids are mixed and then placed in a water bath kettle at 50 ℃ for connection for 1h. Transferring 5-10 mu L of the ligation product into 50 mu L of E.coli XL10-Gold transformation competent cells, and culturing at 37 ℃ overnight to obtain Bmor-1000bp mutation library.
(2) Single colonies on the plates were picked and inoculated into 5mL LB (100. Mu.g/mL Amp) liquid medium, and cultured at 37℃for 8 hours at 220rpm as seed liquid. Preliminary screening was performed using 96 deep well plates. 950. Mu.L of fresh LB (100. Mu.g/mL Amp) medium was added to each well; n-butanol or isobutanol was added to the wells to a final concentration of 10mM, respectively; finally, 50. Mu.L of seed solution was pipetted into each well. After sealing the sealing film, the deep-hole plate was placed in a shaker at 30℃and 220rpm for 16h.
(3) Fluorescence intensity GFP and OD Using microplates 600 And (3) detecting: blowing and beating the mixed bacterial liquid, absorbing 200 mu L, putting into an enzyme-labeled instrument, quantitatively detecting at 30 ℃, and setting parameters as follows: 470nm excitation wavelength, 510nm emission wavelength, gain value of 50; the GFP and OD obtained 600 The value is first subtracted from the background control value, on whichGFP/OD per well was calculated above 600 As relative fluorescence intensity values.
(4) After analysis of the primary screening results, plasmids of the active mutant bacteria were sequenced.
Mutants were determined in which only n-butanol was responsive, specifically: I183T mutant (amino acid sequence shown in sequence table SEQ ID NO.3, nucleotide sequence shown in sequence table SEQ ID NO. 4) in which amino acid at position 183 is mutated from Ile to Thr, D273N mutant (amino acid sequence shown in sequence table SEQ ID NO.5, nucleotide sequence shown in sequence table SEQ ID NO. 6) in which amino acid at position 273 is mutated from Asp to Asn, and I183T/D273N mutant (amino acid sequence shown in sequence table SEQ ID NO.7, nucleotide sequence shown in sequence table SEQ ID NO. 8) in which amino acid at position 183 is mutated from Ile to Thr and amino acid at position 273 is mutated from Asp to Asn 600 The primary screening results are shown in Table 1 and FIG. 2 below, and it is seen that the I183T, D N and I183T/D273N mutants had responses to only N-butanol relative to wild-type Bmor.
TABLE 1 GFP/OD 600
Bmor proteins N-butanol Isobutanol
WT 983 868
I183T/D273N 54.0 0.00
I183T 39.9 0.00
D273N 25.0 0.00
EXAMPLE 2 concentration gradient assay to determine the limit of detection variation of wild type and mutant
The wild BmoR-based biosensor can realize response to 0-40mM n-butanol or isobutanol, and has response to both n-butanol and isobutanol; at substrate concentrations above 40mM, the response values tend to saturate and fail to respond to higher concentrations of alcohol molecules. The specific response of BmoR biosensors based on 1183T/D273N mutants to 0-100mM N-butanol/isobutanol was verified experimentally as follows.
Based on the primary screening result, exogenous addition experiments of N-butanol or isobutanol with concentration gradients are respectively carried out on strains containing the I183T/D273N mutant gene and the wild BmoR gene, response curves are measured, and K is calculated m Response intensity value, etc.
The single clone on the plate was picked up and inoculated into 5mL of LB (100. Mu.g/mLAMP) liquid medium, and cultured at 37℃for 8 hours at 220rpm as a seed solution.
Exogenous addition experiments were performed in sterilized 2ml 96 deep well plates. 950. Mu.L of fresh LB (100. Mu.g/mL Amp) medium is added to each well, n-butanol or isobutanol is added to the medium to make the final concentration of each of the n-butanol or isobutanol be 0, 1, 10, 20, 40, 60, 80 and 100mM, 50. Mu.L of seed solution is finally inoculated to each well, the sealing film is sealed, and the deep-well plate is placed at 30 ℃ and cultured for 16 hours by a shaking table at 220 rpm.
Fluorescence intensity GFP and OD Using microplates 600 And (3) detecting: blowing and beating the mixed bacterial liquid, absorbing 200 mu L, putting into an enzyme-labeled instrument, quantitatively detecting at 30 ℃, and setting parameters as follows: 470nm excitation wavelength and 510nm emission wavelength, the gain value is 50; the GFP and OD obtained 600 The value is first subtracted by the background control value, on the basis of which each is calculatedGFP/OD in individual wells 600 As relative fluorescence intensity values.
With GFP/OD 600 On the ordinate, the final concentrations of n-butanol and isobutanol are respectively plotted on the abscissa, originPro 8.5 or GraphPad Prism 8 software is used for plotting, michaelis fitting is carried out on the data, and K of Bmor mutant on n-butanol and isobutanol is calculated according to the fitting result m Maximum response intensity, etc. (fig. 3).
Screening a random mutation library under the concentration of 10mM substrate, wherein the obtained mutant I183T/D273N has specific response to N-butanol and does not respond to isobutanol; further, the verification is carried out under the condition of 0-100mM gradient concentration, and the result shows that the mutant still keeps specific response to n-butanol and hardly responds to isobutanol under the condition of different n-butanol and isobutanol concentrations. Mapping was performed by OrigingPro 8.5, wild type BmoR at substrate concentration of 0-100mM for K-butanol m K for isobutanol of 3.78 m 4.24; k for N-butanol at substrate concentration of 0-100mM for I183T/D273N mutant m 15.7, K for isobutanol m 33.2; k (K) m As a characterization of affinity, K m The larger the value, the smaller the affinity; k (K) m The smaller the value, the greater the affinity.
Wild-type BmoR is able to respond to 0-40mM n-butanol or isobutanol, and at concentrations above 40mM the response will saturate, so wild-type BmoR cannot distinguish between n-butanol or isobutanol above 40 mM; the calculation results show that the mutant phase is compared with the wild type, K m The value is obviously improved, and the BmoR mutant can realize the specific response (0-100 mM) of the n-butanol with higher concentration; at the same time, N-butanol K of I183T/D273N mutant m A value less than isobutanol K m The values further indicate that the mutant has a greater affinity for n-butanol than for isobutanol. Is consistent with the experimental result.
Example 3 model analysis
Sequencing the I183T/D273N mutant, analyzing the change of amino acid at a mutation site, modeling the Bmor mutant by using software such as AUTODOCK, chimeraX and the like, respectively docking the mutant with substrate small molecules of N-butanol and isobutanol, and analyzing the combination site of the mutant and the two alcohols and the formation condition of hydrogen bonds.
The three-dimensional structure of the wild BmoR protein is used as a template, and the homology modeling is carried out on the I183T/D273N mutant, wherein the homology rate is 99.6%. The mutant structure is further molecularly docked to a substrate molecule (n-butanol or isobutanol). The results showed that the mutant had 2 hydrogen bond interactions with n-butanol (Leu 260, arg 211) in the complex, while no interaction was formed with isobutanol, indicating that n-butanol could bind tightly to the mutant, and K m The results of the value analysis remained consistent, i.e., specific response to n-butanol (fig. 4).
The above examples merely represent a few embodiments of the present invention, which are described in more detail and are not to be construed as limiting the scope of the patent. It should be noted that, for a person skilled in the art, the above embodiments may also make several variations, combinations and improvements, without departing from the scope of the present patent. Therefore, the protection scope of the patent is subject to the claims.
SEQUENCE LISTING
<110> university of Beijing technology
<120> BmoR protein mutant specifically responding to n-butanol and application thereof
<130> 1
<160> 11
<170> PatentIn version 3.5
<210> 1
<211> 669
<212> PRT
<213> Pseudomonas (Pseudomonas butanovora)
<400> 1
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Ile Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asp Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 2
<211> 2010
<212> DNA
<213> Pseudomonas (Pseudomonas butanovora)
<400> 2
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacatct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcgacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 3
<211> 669
<212> PRT
<213> artificial sequence
<400> 3
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Thr Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asp Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 4
<211> 2010
<212> DNA
<213> artificial sequence
<400> 4
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacacct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcgacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 5
<211> 669
<212> PRT
<213> artificial sequence
<400> 5
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Ile Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asn Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 6
<211> 2010
<212> DNA
<213> artificial sequence
<400> 6
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacatct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcaacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 7
<211> 669
<212> PRT
<213> artificial sequence
<400> 7
Met Ser Lys Met Gln Glu Phe Ala Arg Leu Glu Thr Val Ala Ser Met
1 5 10 15
Arg Arg Ala Val Trp Asp Gly Asn Glu Cys Gln Pro Gly Lys Val Ala
20 25 30
Asp Val Val Leu Arg Ser Trp Thr Arg Cys Arg Ala Glu Gly Val Val
35 40 45
Pro Asn Ala Arg Gln Glu Phe Asp Pro Ile Pro Arg Thr Ala Leu Asp
50 55 60
Glu Thr Val Glu Ala Lys Arg Ala Leu Ile Leu Ala Ala Glu Pro Val
65 70 75 80
Val Asp Ala Leu Met Glu Gln Met Asn Asp Ala Pro Arg Met Ile Ile
85 90 95
Leu Asn Asp Glu Arg Gly Val Val Leu Leu Asn Gln Gly Asn Asp Thr
100 105 110
Leu Leu Glu Asp Ala Arg Arg Arg Ala Val Arg Val Gly Val Cys Trp
115 120 125
Asp Glu His Ala Arg Gly Thr Asn Ala Met Gly Thr Ala Leu Ala Glu
130 135 140
Arg Arg Pro Val Ala Ile His Gly Ala Glu His Tyr Leu Glu Ser Asn
145 150 155 160
Thr Ile Phe Thr Cys Thr Ala Ala Pro Ile Tyr Asp Pro Phe Gly Glu
165 170 175
Phe Thr Gly Ile Leu Asp Thr Ser Gly Tyr Ala Gly Asp Met Gly Pro
180 185 190
Val Pro Ile Pro Phe Val Gln Met Ala Val Gln Phe Ile Glu Asn Gln
195 200 205
Leu Phe Arg Gln Thr Phe Ala Asp Cys Ile Leu Leu His Phe His Val
210 215 220
Arg Pro Asp Phe Val Gly Thr Met Arg Glu Gly Ile Ala Val Leu Ser
225 230 235 240
Arg Glu Gly Thr Ile Val Ser Met Asn Arg Ala Gly Leu Lys Ile Ala
245 250 255
Gly Leu Asn Leu Glu Ala Val Ala Asp His Arg Phe Asp Ser Val Phe
260 265 270
Asn Leu Asn Phe Gly Ala Phe Leu Asp His Val Arg Gln Ser Ala Phe
275 280 285
Gly Leu Val Arg Val Ser Leu Tyr Gly Gly Val Gln Val Tyr Ala Arg
290 295 300
Val Glu Pro Gly Leu Arg Val Pro Pro Arg Pro Ala Ala His Ala Arg
305 310 315 320
Pro Pro Arg Pro Ala Pro Arg Pro Leu Asp Ser Leu Asp Thr Gly Asp
325 330 335
Ala Ala Val Arg Leu Ala Ile Asp Arg Ala Arg Arg Ala Ile Gly Arg
340 345 350
Asn Leu Ser Ile Leu Ile Gln Gly Glu Thr Gly Ala Gly Lys Glu Val
355 360 365
Phe Ala Lys His Leu His Ala Glu Ser Pro Arg Ser Lys Gly Pro Phe
370 375 380
Val Ala Val Asn Cys Ala Ala Ile Pro Glu Gly Leu Ile Glu Ser Glu
385 390 395 400
Leu Phe Gly Tyr Glu Glu Gly Ala Phe Thr Gly Gly Arg Arg Lys Gly
405 410 415
Asn Ile Gly Lys Val Ala Gln Ala His Gly Gly Thr Leu Phe Leu Asp
420 425 430
Glu Ile Gly Asp Met Ala Pro Gly Leu Gln Thr Arg Leu Leu Arg Val
435 440 445
Leu Gln Asp Arg Ala Val Met Pro Leu Gly Gly Arg Glu Pro Met Pro
450 455 460
Val Asp Ile Ala Leu Val Cys Ala Thr His Arg Asn Leu Arg Ser Leu
465 470 475 480
Ile Ala Gln Gly Gln Phe Arg Glu Asp Leu Tyr Tyr Arg Leu Asn Gly
485 490 495
Leu Ala Ile Ser Leu Pro Pro Leu Arg Gln Arg Ser Asp Leu Ala Ala
500 505 510
Leu Val Asn His Ile Leu Phe Gln Cys Cys Gly Gly Glu Pro His Tyr
515 520 525
Ser Val Ser Pro Glu Val Met Thr Leu Phe Lys Arg His Ala Trp Pro
530 535 540
Gly Asn Leu Arg Gln Leu His Asn Val Leu Asp Ala Ala Leu Ala Met
545 550 555 560
Leu Asp Asp Gly His Val Ile Glu Pro His His Leu Pro Glu Asp Phe
565 570 575
Val Met Glu Val Asp Ser Gly Leu Arg Pro Ile Glu Glu Asp Gly Ser
580 585 590
Thr Ala Ala His Arg Ala Arg Gln Pro Ala Ser Gly Ser Gly Pro Ala
595 600 605
Lys Lys Leu Gln Asp Leu Ala Leu Asp Ala Ile Glu Gln Ala Ile Glu
610 615 620
Gln Asn Glu Gly Asn Ile Ser Val Ala Ala Arg Gln Leu Gly Val Ser
625 630 635 640
Arg Thr Thr Ile Tyr Arg Lys Leu Arg Gln Leu Ser Pro Thr Gly Cys
645 650 655
His Arg Pro Ala His Trp Ser Gln Ser Arg Ile Gly Thr
660 665
<210> 8
<211> 2010
<212> DNA
<213> artificial sequence
<400> 8
atgtctaaaa tgcaggaatt cgctcgtctg gaaaccgttg cttctatgcg tcgtgctgtt 60
tgggacggta acgaatgcca gccgggtaaa gttgctgacg ttgttctgcg ttcttggacc 120
cgttgccgtg ctgaaggtgt tgttccgaac gctcgtcagg aattcgaccc gatcccgcgt 180
accgctctgg acgaaaccgt tgaagctaaa cgtgctctga tcctggctgc tgaaccggtt 240
gttgacgctc tgatggaaca gatgaacgac gctccgcgta tgatcatcct gaacgacgaa 300
cgtggtgttg ttctgctgaa ccagggtaac gacaccctgc tggaagacgc tcgtcgtcgt 360
gctgttcgtg ttggtgtttg ctgggacgaa cacgctcgtg gtaccaacgc tatgggtacc 420
gctctggctg aacgtcgtcc ggttgctatc cacggtgctg aacactacct ggaatctaac 480
accatcttca cctgcaccgc tgctccgatc tacgacccgt tcggtgaatt caccggtatc 540
ctggacacct ctggttacgc tggtgacatg ggtccggttc cgatcccgtt cgttcagatg 600
gctgttcagt tcatcgaaaa ccagctgttc cgtcagacct tcgctgactg catcctgctg 660
cacttccacg ttcgtccgga cttcgttggt accatgcgtg aaggtatcgc tgttctgtct 720
cgtgaaggta ccatcgtttc tatgaaccgt gctggtctga aaatcgctgg tctgaacctg 780
gaagctgttg ctgaccaccg tttcgactct gttttcaacc tgaactttgg cgcgttcctg 840
gaccacgttc gtcagtctgc tttcggtctg gttcgtgttt ctctgtacgg tggtgttcag 900
gtttacgctc gtgttgaacc gggtctgcgt gttccgccgc gtccggctgc tcacgctcgt 960
ccgccgcgtc cggctccgcg tccgctggac tctctggaca ccggtgacgc tgctgttcgt 1020
ctggctatcg accgtgctcg tcgtgctatc ggtcgtaacc tgtctatcct gatccagggt 1080
gaaaccggtg ctggtaaaga agttttcgct aaacacctgc acgctgaatc tccgcgttct 1140
aaaggtccgt tcgttgctgt taactgcgct gctatcccgg aaggtctgat cgaatctgaa 1200
ctgttcggtt acgaagaagg tgctttcacc ggtggtcgtc gtaaaggtaa catcggtaaa 1260
gttgctcagg ctcacggtgg taccctgttc ctggacgaaa tcggtgacat ggctccgggt 1320
ctgcagaccc gtctgctgcg tgttctgcag gaccgtgctg ttatgccgct gggtggtcgt 1380
gaaccgatgc cggttgacat agcgctggtc tgcgcaaccc accgtaacct gcgttctctg 1440
atcgctcagg gtcagttccg tgaagacctg tactaccgtc tgaacggtct ggctatctct 1500
ctgccgccgc tgcgtcagcg ttctgacctg gctgctctgg ttaaccacat cctgttccag 1560
tgctgcggtg gtgaaccaca ttactctgta agcccggaag ttatgaccct gttcaaacgt 1620
cacgcttggc cgggtaacct gcgtcagctg cacaacgttc tggacgctgc tctggctatg 1680
ctggacgacg gtcacgttat cgaaccgcac cacctgccgg aagacttcgt tatggaagtt 1740
gactctggtc tgcgtccgat cgaagaagac ggttctaccg ctgctcaccg tgctcgtcag 1800
ccggcttctg gttctggtcc ggctaaaaaa ctgcaggacc tggctctgga cgctatcgaa 1860
caggctatcg aacagaacga aggtaacatc tctgttgctg cgcgtcagct gggtgtaagc 1920
cgtaccacca tctaccgtaa actgcgtcag ctgtctccga ccggttgcca ccgtccggct 1980
cactggtctc agtctcgtat cggtacctaa 2010
<210> 9
<211> 138
<212> DNA
<213> Pseudomonas (Pseudomonas butanovora)
<400> 9
gaccttgagg tgaccttgag cgggcagata ccaccaaaat ttcccacgtg ctattatggt 60
tttgctaaag ctctcgacag cgaggagaga ctcgcgaaga taagcaattc gcccgacaga 120
ggtgaatgag gagacggt 138
<210> 10
<211> 524
<212> DNA
<213> Pseudomonas (Pseudomonas butanovora)
<400> 10
ccccccaacg acgtccgtca gagcccggtt cgagtggctt ctatatgccg atcatcggtg 60
gctctattgt ggcggtcagt gacaccggtc gccttcaccc ccacagatag taggtgctgc 120
ggctgctcat gctcctgtcg cggtagcgcg ctgttacgcg accgcccccg gacctcggcg 180
gacagcgcgg aagattggaa acagcccgag cgtgcgtgcc tcgggctgca tccttgccac 240
acccaaccgg attcgtcgga ccgctcgaca ttcgcgttcg ctcccgcggc gccgcgggtg 300
taccgttgcg ttacagatgt acccttcttt aacgtgtaac acacgcctgg agcggccaag 360
agccccgcac cttgcggcgc gtcttcccca ggggcccacc ggttgcggcc ttttgctgcg 420
accgtccatg ctggcacgac acttgctgaa agcgttagag cggaatcggt ccgatggagc 480
attcgaagcc gctaccgaca gcagaacaca caaaggagga agtg 524
<210> 11
<211> 717
<212> DNA
<213> artificial sequence
<400> 11
atgcgtaaag gagaagaact tttcactgga gttgtcccaa ttcttgttga attagatggt 60
gatgttaatg ggcacaaatt ttctgtcagt ggagagggtg aaggtgatgc aacatacgga 120
aaacttaccc ttaaatttat ttgcactact ggaaaactac ctgttccatg gccaacactt 180
gtcactactt tcggttatgg tgttcaatgc tttgcgagat acccagatca tatgaaacag 240
catgactttt tcaagagtgc catgcccgaa ggttatgtac aggaaagaac tatatttttc 300
aaagatgacg ggaactacaa gacacgtgct gaagtcaagt ttgaaggtga tacccttgtt 360
aatagaatcg agttaaaagg tattgatttt aaagaagatg gaaacattct tggacacaaa 420
ttggaataca actataactc acacaatgta tacatcatgg cagacaaaca aaagaatgga 480
atcaaagtta acttcaaaat tagacacaac attgaagatg gaagcgttca actagcagac 540
cattatcaac aaaatactcc aattggcgat ggccctgtcc ttttaccaga caaccattac 600
ctgtccacac aatctgccct ttcgaaagat cccaacgaaa agagagacca catggtcctt 660
cttgagtttg taacagctgc tgggattaca catggcatgg atgaactata caaataa 717

Claims (11)

1. A BmoR mutant protein is characterized in that the mutant is obtained by mutating I183T and D273N on the basis of a wild BmoR protein shown in a sequence table SEQ ID NO.1, and the amino acid sequence of the mutant is shown in SEQ ID NO. 7.
2. Use of the BmoR mutant of claim 1 for detecting a sample containing n-butanol, or for screening a strain producing n-butanol.
3. Use of the BmoR mutant of claim 1 for constructing a biosensor for detecting n-butanol.
4. A gene encoding the Bmor mutant of claim 1.
5. The coding gene of claim 4, wherein the coding gene is shown in a sequence table SEQ ID NO. 8.
6. A recombinant plasmid or recombinant strain comprising the coding gene of claim 4.
7. A biosensor comprising the mutant-encoding gene of claim 4, wherein the Bmor mutant-activated promoter P bmo From P bmo Driven reporter genes and expression elements of promoters expressing BmoR mutants.
8. The biosensor of claim 7, wherein the reporter gene comprises, but is not limited to, a gfp, rfp, cfp, sfgfp, egfp, yfp, ecfp gene.
9. The biosensor of claim 7, wherein the promoter expressing the Bmor mutant is P bmoR
10. The biosensor of claim 7, wherein the sensor is to be defined by P bmoR The started mutant coding gene is connected to colE1 replication initiation site and amp r And P bmo The gfp gene is started;
the promoter P bmo The nucleotide sequence of (2) is shown as SEQ ID NO.10 of the sequence table.
11. Use of the biosensor of claim 7 for detecting n-butanol-containing environmental, food, medical, biological samples, and screening strains producing n-butanol.
CN202110361566.7A 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof Active CN115160415B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110361566.7A CN115160415B (en) 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110361566.7A CN115160415B (en) 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof

Publications (2)

Publication Number Publication Date
CN115160415A CN115160415A (en) 2022-10-11
CN115160415B true CN115160415B (en) 2024-02-09

Family

ID=83476148

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110361566.7A Active CN115160415B (en) 2021-04-02 2021-04-02 BmoR protein mutant specifically responding to n-butanol and application thereof

Country Status (1)

Country Link
CN (1) CN115160415B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110615832A (en) * 2019-09-27 2019-12-27 北京理工大学 Bmor mutant for efficiently screening isobutanol high-yield strains
CN110885777A (en) * 2019-08-19 2020-03-17 山东汇冠康博生物科技有限公司 Method for screening isobutanol high-yield strain by using Bmor biosensor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8552169B2 (en) * 2009-04-24 2013-10-08 The Regents Of The University Of California Transcription factor-based biosensor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110885777A (en) * 2019-08-19 2020-03-17 山东汇冠康博生物科技有限公司 Method for screening isobutanol high-yield strain by using Bmor biosensor
CN110615832A (en) * 2019-09-27 2019-12-27 北京理工大学 Bmor mutant for efficiently screening isobutanol high-yield strains

Also Published As

Publication number Publication date
CN115160415A (en) 2022-10-11

Similar Documents

Publication Publication Date Title
Kataoka et al. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun
EP1728866B1 (en) Luciferase expression cassettes and methods of use
CN104781419A (en) Sensor for nadp (h) and development of alcohol dehydrogenases
CN113061591A (en) Novel firefly luciferase mutant, preparation method and application thereof
CN116113643A (en) Synthetic expression system
JP2003509029A5 (en)
US6737245B1 (en) Luciferase expression cassettes and methods of use
CN105646716A (en) A gene-encoded cyclic adenylic acid fluorescence probe, and a preparing method and applications thereof
CN105585625B (en) Enhanced green fluorescent protein
CN115160415B (en) BmoR protein mutant specifically responding to n-butanol and application thereof
CN113354745A (en) Composition and method for large-scale production of fibroblast growth factor
CN115181168B (en) BmoR protein mutant insensitive to ethanol and specifically responsive to n-butanol
CN115991746A (en) Bmor mutant specifically responding to isobutanol and application thereof
US7067282B2 (en) Compositions and methods using the yeast YLR110C promoter
CN115991748A (en) BmoR mutant-based high-sensitivity biosensor
CN115991747A (en) BmoR mutant-based high-sensitivity biosensor
CN116023447A (en) BmoR mutant-based wide-area biosensor
CN112175980A (en) Method for improving activity of polymerase large fragment by site-directed mutagenesis and application
CN115181167B (en) Screening method of ethanol production strain based on BmoR mutant
CN112831482B (en) Method for rapidly detecting PRPP and biosensor used by same
CN109810957A (en) Recombinate Gluc
CN114807204B (en) Recombinant vector plasmid, salicylic acid biosensor, construction method and application
KR101550217B1 (en) Recombinant vector for foreign gene expression without biological circuit interference of host cell and uses thereof
WO2024000408A1 (en) Luciferase mutant and use thereof
CN113621585B (en) Taq DNA polymerase and endonuclease chimera, and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant